Atherosclerosis
Volume 197, Issue 2 , Pages 572-578 , April 2008

Apolipoprotein A-IMilano/POPC complex attenuates post-ischemic ventricular dysfunction in the isolated rabbit heart

  • Marta Marchesi

      Affiliations

    • Department of Pharmacological Sciences, University of Milan, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 02 50318328; fax: +39 02 50318284.
    • ,
  • Erin A. Booth

      Affiliations

    • Department of Pharmacology, University of Michigan Medical School, Ann Arbor, MI, USA
    • ,
  • Giuseppe Rossoni

      Affiliations

    • Department of Pharmacology, Chemotherapy and Medical Toxicology, University of Milan, Italy
    • ,
  • Ricardo A. García

      Affiliations

    • Esperion Therapeutics, Division of Pfizer Global Research and Development, Ann Arbor, MI, USA
    • ,
  • Knut R. Hill

      Affiliations

    • Esperion Therapeutics, Division of Pfizer Global Research and Development, Ann Arbor, MI, USA
    • ,
  • Cesare R. Sirtori

      Affiliations

    • Department of Pharmacological Sciences, University of Milan, Italy
    • ,
  • Charles L. Bisgaier

      Affiliations

    • Department of Pharmacology, University of Michigan Medical School, Ann Arbor, MI, USA
    • Esperion Therapeutics, Division of Pfizer Global Research and Development, Ann Arbor, MI, USA
    • ,
  • Benedict R. Lucchesi

      Affiliations

    • Department of Pharmacology, University of Michigan Medical School, Ann Arbor, MI, USA

Received 17 April 2007 ,Revised 17 August 2007 ,Accepted 20 August 2007.

References 

  1. Franceschini G. Epidemiologic evidence for high-density lipoprotein cholesterol as a risk factor for coronary artery disease. Am J Cardiol. 2001;88:9N–13N
  2. Calabresi L, Rossoni G, Franceschini G. Synthetic high density lipoproteins for the treatment of myocardial ischemia/reperfusion injury. Pharmacol Ther. 2006;111:836–854
  3. Mackness MI, Durrington PN, Mackness B. How high-density lipoprotein protects against the effects of lipid peroxidation. Curr Opin Lipidol. 2000;11:383–388
  4. Calabresi L, Gomaraschi M, Franceschini G. Endothelial protection by high-density lipoproteins: from bench to bedside. Arterioscler Thromb Vasc Biol. 2003;23:1724–1731
  5. Kawakami A, Yoshida M. Remnant lipoproteins and atherogenesis. J Atheroscler Thromb. 2005;12(2):73–76
  6. Weisgraber KH, Rall SC, Bersot TP, et al. Apolipoprotein A-IMilano. Detection of normal A-I in affected subjects and evidence for a cysteine for arginine substitution in the variant A-I. J Biol Chem. 1983;258:2508–2513
  7. Franceschini G, Sirtori CR, Bosisio E, et al. Relationship of the phenotypic expression of the A-IMilano apoprotein with plasma lipid and lipoprotein patterns. Atherosclerosis. 1985;58:159–174
  8. Sirtori CR, Calabresi L, Franceschini G, et al. Cardiovascular status of carriers of the apolipoprotein A-I(Milano) mutant: the Limone sul Garda study. Circulation. 2001;103:1949–1954
  9. Franceschini G, Calabresi L, Tosi C, et al. Apolipoprotein AIMilano. Disulfide-linked dimers increase high density lipoprotein stability and hinder particle interconversion in carrier plasma. J Biol Chem. 1990;265:12224–12231
  10. Franceschini G, Calabresi L, Chiesa G, et al. Increased cholesterol efflux potential of sera from ApoA-IMilano carriers and transgenic mice. Arterioscler Thromb Vasc Biol. 1999;19:1257–1262
  11. Chiesa G, Monteggia E, Marchesi M, et al. Recombinant apolipoprotein A-I(Milano) infusion into rabbit carotid artery rapidly removes lipid from fatty streaks. Circ Res. 2002;90:974–980
  12. Kaul S, Rukshin V, Santos R, et al. Intramural delivery of recombinant apolipoprotein A-IMilano/phospholipid complex (ETC-216) inhibits in-stent stenosis in porcine coronary arteries. Circulation. 2003;107:2551–2554
  13. Bielicki JK, Oda MN. Apolipoprotein A-I(Milano) and apolipoprotein A-I(Paris) exhibit an antioxidant activity distinct from that of wild-type apolipoprotein A-I. Biochemistry. 2002;41:2089–2096
  14. Nissen SE, Tsunoda T, Tuzcu EM, et al. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA. 2003;290:2292–2300
  15. Zweier JL, Flaherty JT, Weisfeldt ML. Direct measurement of free radical generation following reperfusion of ischemic myocardium. Proc Natl Acad Sci USA. 1987;84:1404–1407
  16. Bolli R. Preconditioning: a paradigm shift in the biology of myocardial ischemia. Am J Physiol Heart Circ Physiol. 2007;292:H19–H27
  17. Bisgaier CL, Sachdev OP, Lee ES, et al. Effect of lecithin:cholesterol acyltransferase on distribution of apolipoprotein A-IV among lipoproteins of human plasma. J Lipid Res. 1987;28:693–703
  18. Lucchesi BR. Free radicals and tissue injury. Dialog Cardiovasc Med. 1998;1:3–22
  19. Ambrosio G, Flaherty JT, Duilio C, et al. Oxygen radicals generated at reflow induce peroxidation of membrane lipids in reperfused hearts. J Clin Invest. 1991;87:2056–2066
  20. Navab M, Hama SY, Anantharamaiah GM, et al. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3. J Lipid Res. 2000;41:1495–1508
  21. Navab M, Hama SY, Cooke CJ, et al. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1. J Lipid Res. 2000;41:1481–1494
  22. Calara F, Dimayuga P, Niemann A, et al. An animal model to study local oxidation of LDL and its biological effects in the arterial wall. Arterioscler Thromb Vasc Biol. 1998;18:884–893
  23. Sivonova M, Tatarkova Z, Durackova Z, et al. Relationship between antioxidant potential and oxidative damage to lipids, proteins and DNA in aged rats. Physiol Res. 2006;
  24. Calabresi L, Rossoni G, Gomaraschi M, et al. High-density lipoproteins protect isolated rat hearts from ischemia–reperfusion injury by reducing cardiac tumor necrosis factor-alpha content and enhancing prostaglandin release. Circ Res. 2003;92:330–337
  25. Marchesi M, Booth EA, Davis T, et al. Apolipoprotein A-IMilano and 1-palmitoyl-2-oleoyl phosphatidylcholine complex (ETC-216) protects the in vivo rabbit heart from regional ischemia–reperfusion injury. J Pharmacol Exp Ther. 2004;311:1023–1031
  26. Ameli S, Hultgardh-Nilsson A, Cercek B, et al. Recombinant apolipoprotein A-I Milano reduces intimal thickening after balloon injury in hypercholesterolemic rabbits. Circulation. 1994;90:1935–1941
  27. Shah PK, Wang L, Pan T, et al. Comparative anti-atherogenic effects of macrophage specific expression of apolipoprotein A-I Milano versus apolipoprotein A-I wild type in apo E/apo A-I double knockout mice. Circulation (Supplement). 2005;112:258

PII: S0021-9150(07)00532-1

doi: 10.1016/j.atherosclerosis.2007.08.028

Atherosclerosis
Volume 197, Issue 2 , Pages 572-578 , April 2008

Article Tools

* Image Usage & Resolution